Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease ...

French researchers have identified a blood test that could revolutionize how amyotrophic lateral sclerosis (ALS) is diagnosed and monitored. A team from Montpellier has shown that measuring a protein ...

Four serum neurofilament light chain tests show high accuracy in diagnosing ALS and predicting its progression, new research suggests.

Under current regulations, spouses can receive benefits only if the veteran lived with the disability for at least eight ...

with disease progression being relatively slow for heterozygous forms but very rapid for the homozygous form. The study also identified variants in other ALS-associated genes, including C9orf72 ...

Bayesian analysis and interim futility checks allowed rapid and efficient testing of multiple drugs in parallel. Challenges included variability in disease progression (a common issue in ALS ...

with disease progression being relatively slow for heterozygous forms but very rapid for the homozygous form. The study also identified variants in other ALS-associated genes, including C9orf72 ...

Four potential treatments being trailed by Biohaven, Prilenia Therapeutics, Clene Nanomedicine and UCB for amyotrophic lateral sclerosis (ALS) have fallen short of their endpoints as part of a US ...

with disease progression being relatively slow for heterozygous forms but very rapid for the homozygous form. The study also identified variants in other ALS-associated genes, including C9orf72 ...